Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Bladder Cancer Treatment

How is Bladder Cancer Treated?
Last updated and reviewed on May 23, 2026.
Treatment for bladder cancer depends on the stage and grade of the cancer, your age, and your overall health. There are several main types of treatment, and they are often used in combination. Your care team will likely include a urologist (a doctor who specializes in urinary conditions), a medical oncologist (who oversees cancer medicines), and a radiation oncologist (who specializes in radiation therapy).
Surgery: Surgery is a major part of treatment for most bladder cancers. For non-muscle-invasive bladder cancer, the most common surgery is called transurethral resection of bladder tumor (TURBT). In this procedure, a cystoscope is inserted into the bladder through the urethra, and the tumor is cut out or burned away using electric current. No cuts are made in the skin. For muscle-invasive bladder cancer that has not yet spread, the standard surgery is radical cystectomy, removal of the entire bladder, along with nearby tissues and lymph nodes. For men, this often includes the prostate. For women, it may include the uterus and part of the vagina. A new way for urine to leave the body (called a urinary diversion) is created during this surgery.
Intravesical Therapy: For early-stage bladder cancer, medicines can be placed directly into the bladder through a catheter (a thin tube). The most common intravesical therapy is BCG (Bacillus Calmette-Guérin), a weakened form of bacteria that stimulates the immune system to attack remaining cancer cells. Chemotherapy drugs can also be given this way.
Chemotherapy: Chemotherapy uses powerful drugs to kill cancer cells throughout the body. It can be given before surgery (neoadjuvant chemotherapy) to shrink the tumor, after surgery (adjuvant chemotherapy) to kill any remaining cancer cells, or as the main treatment for advanced bladder cancer. Common chemotherapy drugs used for bladder cancer include cisplatin and gemcitabine.
Immunotherapy: Immunotherapy is a type of treatment that uses medicines to help your own immune system recognize and destroy cancer cells. BCG (given into the bladder) is a form of immunotherapy used for early-stage cancer. For advanced bladder cancer, newer immunotherapy medicines called checkpoint inhibitors, such as pembrolizumab, are now an important part of treatment. The combination of pembrolizumab and enfortumab vedotin has recently become a new standard of care for metastatic bladder cancer.
Radiation Therapy: Radiation uses high-energy X-rays to kill cancer cells. It is sometimes used along with chemotherapy as an alternative to bladder removal surgery, a strategy called trimodality therapy, which allows some patients to keep their bladder. It is also used for palliative treatment to relieve symptoms in advanced cancer.
Targeted Therapy: Targeted therapies are medicines that attack specific features of cancer cells. For example, drugs that target the FGFR3 gene mutation (like erdafitinib) have been approved for use in bladder cancer patients whose tumors have this specific mutation.
TAR-200: A New “Pretzel” Treatment for Bladder Cancer: A new bladder cancer treatment called INLEXZO™ (gemcitabine intravesical system) is a pretzel-shaped, flexible silicone device approved to treat adult patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), giving hope to many patients with bladder cancer that has come back after treatment. TAR-200 is a first-in-class small soft device that is placed inside the bladder through a thin tube called a catheter. Once inside the bladder, it curls into a pretzel-like shape so it stays in place. The device slowly releases a chemotherapy medicine called INLEXZO™ (gemcitabine intravesical system) directly into the bladder over several weeks. This allows the medicine to stay in contact with the cancer longer than standard bladder treatments. Read more about this new treatment in this HealthTree article TAR-200: INLEXZO™ (gemcitabine intravesical system) A New “Pretzel” Treatment for Bladder Cancer
For some patients, a combination of treatments is used at the same time. For example, chemotherapy and immunotherapy are often given together for advanced bladder cancer. Radiation and chemotherapy may be used together for cancers that cannot be surgically removed. Doctors also sometimes give treatments before surgery, called neoadjuvant therapy, to shrink the tumor first and make it easier to remove. The order and combination of treatments depends on your specific cancer, and your care team will explain why they are recommending the approach they have chosen for you.
Adjusting to a urinary diversion
If your treatment included removing your bladder, a procedure called a radical cystectomy, your surgeon created a new way for urine to leave your body. This is called a urinary diversion, and there are a few different types. An ileal conduit uses a short piece of intestine to carry urine to an opening on your abdomen called a stoma, where it collects in a pouch worn against the skin. A neobladder is an internal pouch built from intestine and connected to your urethra, so you urinate in a more familiar way but must learn a new technique to empty it. A continent cutaneous reservoir is an internal pouch that you drain several times a day using a catheter through a small opening on your abdomen.
Whichever type you have, adjusting takes time, and the emotional adjustment often takes longer than the physical one. It is very common to feel grief, embarrassment, or a sense that your body is no longer yours. Many people worry about odor, leaks, whether the pouch will be visible under clothing, and what will happen the first time they are away from home for a full day. These worries are practical, not vain, and they deserve real answers rather than reassurance.
What can help:
Work with a WOC nurse. A wound, ostomy, and continence nurse is a specialist in exactly this. They can help you find pouching supplies that fit your body, troubleshoot leaks and skin irritation, and answer the questions you may feel awkward asking anyone else. Ask your care team for a referral, and know that you can go back to them months or years later when something changes.
Give yourself a learning curve. The first weeks involve a lot of trial and error with supplies, timing, and routines. Most people report that what felt overwhelming at the start becomes a background part of the day within a few months.
Talk to someone who has one. This is the single thing most patients say helped most. Reading about a urostomy is very different from talking with someone who has lived with one for ten years and can tell you what they wear to the beach. The United Ostomy Associations of America has more than 270 local support groups plus an online discussion board, and many bladder cancer support groups include members with every type of diversion.
Have the intimacy conversation. Surgery can affect sexual function, sensation, and how you feel about being seen by a partner. These effects are real, and they are also, in many cases, treatable or workable. Talk openly with your partner if you have one, and ask your doctor directly about options. Some people find it easier to raise the topic with a nurse or a sex therapist who works with cancer patients.
Expect good days and hard days. A leak in public or a skin problem that will not settle can knock you back emotionally even long after you have adjusted. That does not mean you are back at the beginning.
Living with surveillance and the fear of recurrence
Bladder cancer follow-up is unusually frequent. If you were treated for non-muscle invasive bladder cancer, you will likely have cystoscopies every three months at first, then less often over a period of years. This close monitoring exists for a good reason. It catches recurrence early, when it is easiest to treat.
But there is an emotional cost that does not get talked about enough. Many patients describe a cycle that repeats with every appointment: dread building in the days beforehand, difficulty sleeping the night before, a tense wait for results, and then relief that lasts a few weeks before the next cycle begins. People sometimes call this scan anxiety. It is extremely common, and it does not mean you are coping badly. It means you are a person who has been told that something can come back and are being checked for it over and over.
What can help:
Name the pattern. Simply recognizing that the anxiety follows a predictable arc around your appointment schedule makes it easier to plan around, and easier to recognize as temporary rather than as a sign something is wrong.
Schedule strategically. Where you can, book appointments early in the day and early in the week so you spend less time waiting, and ask how and when results will be communicated so you are not checking your phone for days.
Plan something for afterward. Having a small thing you look forward to on the day of a cystoscopy, whether that is a meal out or a walk somewhere you like, gives the day a shape that is not only about the procedure.
Bring someone with you. Company in the waiting room helps, and so does having someone to talk to on the drive home.
Ask about the procedure itself. If the cystoscopy is physically uncomfortable enough that you dread it, say so. There are differences in scope type, numbing gel, and sedation options, and your urologist may be able to make it easier.
Get help if it is not easing. If anxiety is affecting your sleep, your work, or your relationships between appointments, that is worth treating. Cognitive behavioral therapy is effective for exactly this kind of anticipatory anxiety, and an oncology social worker or counselor can help.
Over time, most people find the cycle softens. The appointments do not stop mattering, but they take up less room in the rest of your life.
Supportive care during treatment
When people hear the term "supportive care," they sometimes think it only applies to patients who are very sick or near the end of life. That is a common misunderstanding. Supportive care, also called palliative care, is actually for anyone going through a serious illness, at any stage, and at any point during treatment. Its goal is to help you feel as well as possible while you are fighting cancer. Palliative care is defined as medical care provided by an interdisciplinary team focused on the relief of suffering and support for the best possible quality of life for patients facing serious life-threatening illness and their families, aiming to identify and address the physical, psychological, spiritual, and practical burdens of illness.
The broad term "supportive care" for patients with advanced bladder cancer can include a variety of medical, psychological, and alternative therapies, all of which can help ease symptoms. This includes things like medications to control pain, nausea, or shortness of breath; counseling to help with anxiety and depression; nutrition support; and physical therapy to help keep your strength up. Interventions such as guided imagery, breathing techniques, and educational tools can have a positive impact on common psychological symptoms such as anxiety and depression, and the involvement of social and spiritual support for patients and families can certainly impact physical symptoms as well as overall quality of life.
Research has shown that starting supportive care early makes a real difference. A landmark study published in the New England Journal of Medicine found that patients with advanced bladder cancer who received early palliative care alongside their regular cancer treatment had better quality of life and mood compared to those who only received standard oncology care1. Rates of depression also differed significantly between the groups, with approximately half as many patients in the palliative care group reporting clinically significant depressive symptoms. This study helped change the way the medical community thinks about palliative care, shifting the view from a last resort to an essential part of treatment from the very beginning.
Palliative care is rapidly becoming an important part of cancer care, and patients with advanced bladder cancer clearly experience benefits in quality of life and potentially even in overall survival when palliative care is incorporated early on after diagnosis. The palliative care team works alongside your oncology team, not instead of them. The team should include the patient's treating physician, nurses, as well as supportive care experts such as social workers, psychologists, spiritual counselors, pulmonary rehabilitation specialists, case managers, pain specialists, and dietitians. This group of people works together to make sure all of your needs are being met, not just your medical ones.
It is important to know that supportive care is not giving up. The term palliative care has often been misunderstood as synonymous with hospice care, but while hospice care is specifically provided to patients who are no longer receiving disease-modifying treatment, palliative care is provided to patients with serious illness regardless of whether their treatment intent is curative or supportive. You can receive supportive care while also receiving chemotherapy, immunotherapy, surgery, or any other active treatment. Ask your care team about what supportive care services are available to you, because you deserve to feel as comfortable and supported as possible throughout your entire treatment journey.
Follow-up care after treatment ends
When your main cancer treatment ends, you move into a phase called survivorship. This does not mean your doctors say goodbye; instead, you begin follow-up care to make sure you stay healthy. The primary goal of these checkups is to watch for any signs of the cancer returning and to help you manage any long-term side effects from your treatment.
Follow-up care after bladder cancer treatment is extremely important. Bladder cancer has one of the highest recurrence rates of any cancer, meaning it often comes back after treatment, sometimes in the same place and sometimes elsewhere in the urinary tract. Regular follow-up visits allow your doctor to catch any recurrence early, when it is most treatable.
Your doctor will give you a survivorship care plan, which is like a map for your future health. These regular checkups help catch any changes early when they are easiest to handle.
After treatment for non-muscle-invasive bladder cancer, most patients have a cystoscopy (a look inside the bladder) every three months for the first two years, then every six months, and eventually once a year if no recurrence is detected. Urine tests are typically done at these visits as well.
After radical cystectomy (bladder removal), follow-up visits include physical exams, blood tests, imaging scans, and urine tests on a regular schedule. These visits also monitor the function of your urinary diversion and check for long-term side effects of surgery and chemotherapy.
Follow-up care also includes managing any long-term side effects from treatment, such as changes in urinary function, sexual health concerns, or the physical and emotional adjustment to living with a urinary diversion. Your team will help you manage these challenges and refer you to specialists (like urologists, physical therapists, or sexual health counselors) as needed. Survivorship care plans are written documents that summarize your cancer treatment and outline the plan for ongoing monitoring. Ask your care team for one if you have not already received it.
It is very important to keep your own copies of your medical records and treatment summaries. You can do this using HealthTree and by electronically connecting all your medical records to your phone. Since you might see different doctors in the future, having a record of exactly what treatments you received helps them give you the best care. Follow-up care is all about staying proactive and giving you the peace of mind to move forward with your life after cancer.
What’s Next: Click the Bladder Cancer Guide page to see all the guides about bladder cancer.